To view this email as a web page, click here.
 
OPIOID ACTIONS
 
DEA wants to slash opioid production
The Drug Enforcement Administration wants to slash the production of opioid painkillers by 20% in 2018.
Read more
 
FDA approves novel leukemia, hepatitis C drugs
FDA approved the first treatment for patients with a certain type of acute myeloid leukemia, as well as 2 new drugs to treat hepatitis C.
Read more
 
FDA to drug-maker: pull opioid pain drug
FDA requested that Endo Pharmaceuticals remove its opioid pain medication, Opana ER (oxymorphone hydrochloride), from the market.
Read more
 
SURVEY
 
State of the Industry Survey 2017
Take three minutes to answer our State of the Industry Survey. As a thank-you to survey-takers, when the survey closes, we will hold a drawing to give away not one, but two $200 Visa gift cards.
Take survey
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.